Elliot Neil DeHaan MD
HIV/AIDS Medicine
Director Vaccine Clinical Research & Development Pfizer, Inc.
Join to View Full Profile
401 N Middletown RdPearl River, NY 10965
Phone+1 646-285-5372
Dr. DeHaan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Elliot DeHaan, MD is an Infectious Disease specialist in Pearl River, NY. He completed his education and training at institutions like Harvard University and NYU School of Medicine, and served in various capacities at Pfizer, Weill Cornell, and SUNY Downstate. Dr. DeHaan has published work in notable medical journals including The New England Journal of Medicine and Clinical Infectious Diseases.
Education & Training
NYU Grossman School of MedicineFellowship, Infectious Disease, 2008 - 2010
Tufts Medical CenterResidency, Internal Medicine, 2005 - 2008
Rutgers New Jersey Medical SchoolClass of 2005
Harvard UniversityAB, Biomedical Engineering Sciences, 1995 - 1999
Certifications & Licensure
NY State Medical License 2008 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 6 citationsBivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions.Matthew Davis, William Towner, Elliot DeHaan, Qin Jiang, Wen Li
Clinical Infectious Diseases. 2025-04-30 - 3 citationsImmunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.Natalia Castillo Almeida, Lalitha Parameswaran, Elliot N DeHaan, Hayley Wyper, Farah Rahman
Vaccines. 2025-03-19 - 20 citationsRENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, Qin Jiang, Daniel Eiras
The New England Journal of Medicine. 2024-10-17
Press Mentions
New Guideline for Replacement ART: CAB/RPV LA Not for EveryoneAugust 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
